MAT
62
2
SBUX
36
-3
BF.B
31
2
LOW
50
4
BRK.B
33
-3
HRL
27
-3
EXPE
74
2
NUE
48
-2
CMA
50
-2
EMN
48
-2
LYB
37
12
ZTS
27
-9
CFG
52
-2
L
47
-5
DNB
66
2
HCA
50
2
TEL
60
-6
NWL
54
-2
PNC
52
-3
SEE
45
-4
MAT
62
2
SBUX
36
-3
BF.B
31
2
LOW
50
4
BRK.B
33
-3
HRL
27
-3
EXPE
74
2
NUE
48
-2
CMA
50
-2
EMN
48
-2
LYB
37
12
ZTS
27
-9
CFG
52
-2
L
47
-5
DNB
66
2
HCA
50
2
TEL
60
-6
NWL
54
-2
PNC
52
-3
SEE
45
-4
Financhill
Back

Avenue Therapeutics Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
19

ATXI
Avenue Therapeutics

Last Price:
2.21
Seasonality Move:
8.52%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Avenue Therapeutics Price Quote

$2.21
0.00 (-0.13%)
(Updated: November 5, 2024 at 4:20 PM ET)

Avenue Therapeutics Key Stats

Sell
19
Avenue Therapeutics (ATXI) is a Sell
Day range:
$2.15 - $2.45
52-week range:
$1.70 - $26.47
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.66%
Volume:
47.9K
Avg. volume:
66.3K
1-year change:
-88.21%
Market cap:
$3.2M
Revenue:
$0
EPS:
$-15.45

How Much Does Avenue Therapeutics Make?

Data Unavailable

Is Avenue Therapeutics Growing As A Company?

Data Unavailable

Avenue Therapeutics Stock Price Performance

What Is Avenue Therapeutics 52-Week High & Low?

Avenue Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Avenue Therapeutics?

Is Avenue Therapeutics Cash Flow Positive?

  • What Is ATXI Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.6M
  • What Is Avenue Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $12.9M
  • What Is Avenue Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Avenue Therapeutics Return On Invested Capital

Data Unavailable

Avenue Therapeutics Earnings Date & Stock Price

Avenue Therapeutics Competitors

  • Who Are Avenue Therapeutics's Competitors?
    Below is a list of companies who compete with Avenue Therapeutics or are related in some way:
    • Checkpoint Therapeutics Inc (CKPT)
    • Journey Medical Corp (DERM)
    • Fortress Biotech Inc (FBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)

Avenue Therapeutics Dividend Yield

Avenue Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 12.00
Upside from Last Price: 442.3%

Major Shareholders

  • How many ATXI shares are owned by institutional investors?
    3.7M ATXI shares are owned by institutional investors
  • How many ATXI shares are owned by insiders?
    0 ATXI shares are owned by insiders